Membranous glomerulonephritis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
← Older edit
VisualWikitext
Shussain (talk | contribs)
nocaptcha
681 edits
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Bot: Removing from Primary care
 
(26 intermediate revisions by 3 users not shown)
Line 2: Line 2:
{{Membranous glomerulonephritis}}
{{Membranous glomerulonephritis}}


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{SAH}}
==Overview==
==Overview==
The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000. The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide. In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000. The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years. Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population. Membranous glomerulonephritis affects men and women equally. Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
* The membranous glomerulonephritis is a rare disease.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid28065518">{{cite journal |vauthors=Cattran DC, Brenchley PE |title=Membranous nephropathy: integrating basic science into improved clinical management |journal=Kidney Int. |volume=91 |issue=3 |pages=566–574 |date=March 2017 |pmid=28065518 |doi=10.1016/j.kint.2016.09.048 |url=}}</ref>
===Incidence===
===Incidence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref>
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.


===Prevalence===
===Prevalence===
*The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
*The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.<ref name="McGroganFranssen2010">{{cite journal|last1=McGrogan|first1=A.|last2=Franssen|first2=C. F. M.|last3=de Vries|first3=C. S.|title=The incidence of primary glomerulonephritis worldwide: a systematic review of the literature|journal=Nephrology Dialysis Transplantation|volume=26|issue=2|year=2010|pages=414–430|issn=0931-0509|doi=10.1093/ndt/gfq665}}</ref><ref name="pmid24715030" />
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Mortality rate===
*In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
*In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000<ref name="McGroganFranssen2010" /><ref name="pmid24715030" /><ref name="pmid27365535">{{cite journal |vauthors=Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF |title=Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China |journal=J. Am. Soc. Nephrol. |volume=27 |issue=12 |pages=3739–3746 |date=December 2016 |pmid=27365535 |pmc=5118492 |doi=10.1681/ASN.2016010093 |url=}}</ref>
*The case-fatality rate/mortality rate of [disease name] is approximately [number range].


===Age===
===Age===
*Patients of all age groups may develop membranous glomerulonephritis.
*Patients of all age groups may develop membranous glomerulonephritis
*The incidence of Membranous Glomerulonephritis increases with age; the median age at diagnosis is 40 years.
*The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years<ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref>
*Membranous Glomerulonephritis commonly affects individuals older than 40 years of age.


===Race===
===Race===


*membranous glomerulopathy usually affects individuals of the caucasian race.
*Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref>


===Gender===
===Gender===
* Membranous glomerulonephritis affects men and women equally.
* Membranous glomerulonephritis affects men and women equally.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref>


===Region===
===Region===


* Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.
* Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.<ref name="pmid24715030">{{cite journal |vauthors=Debiec H, Ronco P |title=Immunopathogenesis of membranous nephropathy: an update |journal=Semin Immunopathol |volume=36 |issue=4 |pages=381–97 |date=July 2014 |pmid=24715030 |doi=10.1007/s00281-014-0423-y |url=}}</ref><ref name="TangYao2017">{{cite journal|last1=Tang|first1=Lijun|last2=Yao|first2=Jing|last3=Kong|first3=Xianglei|last4=Sun|first4=Qing|last5=Wang|first5=Zunsong|last6=Zhang|first6=Ying|last7=Wang|first7=Ping|last8=Liu|first8=Yipeng|last9=Li|first9=Wenbin|last10=Cui|first10=Meiyu|last11=Zhen|first11=Junhui|last12=Xu|first12=Dongmei|title=Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China|journal=Nephrology|volume=22|issue=2|year=2017|pages=168–173|issn=13205358|doi=10.1111/nep.12739}}</ref>\
 
===Developed Countries===
 
===Developing Countries===


==References==
==References==
Line 44: Line 37:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category: (name of the system)]]
 
[[Category:Nephrology]]
[[Category:Up-to-date]]

Latest revision as of 22:41, 29 July 2020

Membranous glomerulonephritis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Membranous glomerulonephritis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

CT

Ultrasound

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Membranous glomerulonephritis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Membranous glomerulonephritis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Membranous glomerulonephritis epidemiology and demographics

CDC on Membranous glomerulonephritis epidemiology and demographics

Membranous glomerulonephritis epidemiology and demographics in the news

Blogs on Membranous glomerulonephritis epidemiology and demographics

Directions to Hospitals Treating Membranous glomerulonephritis

Risk calculators and risk factors for Membranous glomerulonephritis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Ahsan Hussain, M.D.[2]

Overview

The incidence rate of membranous glomerulonephritis is 27 per 100.000. The prevalence rate of membranous glomerulonephritis is 690 per 100,000. The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide. In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000. The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years. Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population. Membranous glomerulonephritis affects men and women equally. Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.

Epidemiology and Demographics

  • The membranous glomerulonephritis is a rare disease.[1][2]

Incidence

  • The incidence of membranous glomerulopathy is approximately 27 per 100,000 individuals worldwide.[1]

Prevalence

  • The prevalence of membranous glomerulonephritis is approximately 690 per 100,000 individuals worldwide.[1][3]

Mortality rate

  • In 2001, the mortality rate of membranous glomerulonephritis is approximately 380 per 100,000[1][3][4]

Age

  • Patients of all age groups may develop membranous glomerulonephritis
  • The incidence of membranous glomerulonephritis increases with age; the median age at diagnosis is 40 years[5]

Race

  • Membranous glomerulopathy usually affects individuals of the caucasian race and chinese population.[3][5]

Gender

  • Membranous glomerulonephritis affects men and women equally.[3]

Region

  • Membranous glomerulonephritis tends to affect Caucasian population and Chinese population.[3][5]\

References

  1. ↑ 1.0 1.1 1.2 1.3 McGrogan, A.; Franssen, C. F. M.; de Vries, C. S. (2010). "The incidence of primary glomerulonephritis worldwide: a systematic review of the literature". Nephrology Dialysis Transplantation. 26 (2): 414–430. doi:10.1093/ndt/gfq665. ISSN 0931-0509.
  2. ↑ Cattran DC, Brenchley PE (March 2017). "Membranous nephropathy: integrating basic science into improved clinical management". Kidney Int. 91 (3): 566–574. doi:10.1016/j.kint.2016.09.048. PMID 28065518.
  3. ↑ 3.0 3.1 3.2 3.3 3.4 Debiec H, Ronco P (July 2014). "Immunopathogenesis of membranous nephropathy: an update". Semin Immunopathol. 36 (4): 381–97. doi:10.1007/s00281-014-0423-y. PMID 24715030.
  4. ↑ Xu X, Wang G, Chen N, Lu T, Nie S, Xu G, Zhang P, Luo Y, Wang Y, Wang X, Schwartz J, Geng J, Hou FF (December 2016). "Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China". J. Am. Soc. Nephrol. 27 (12): 3739–3746. doi:10.1681/ASN.2016010093. PMC 5118492. PMID 27365535.
  5. ↑ 5.0 5.1 5.2 Tang, Lijun; Yao, Jing; Kong, Xianglei; Sun, Qing; Wang, Zunsong; Zhang, Ying; Wang, Ping; Liu, Yipeng; Li, Wenbin; Cui, Meiyu; Zhen, Junhui; Xu, Dongmei (2017). "Increasing prevalence of membranous nephropathy in patients with primary glomerular diseases: A cross-sectional study in China". Nephrology. 22 (2): 168–173. doi:10.1111/nep.12739. ISSN 1320-5358.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Membranous_glomerulonephritis_epidemiology_and_demographics&oldid=1640607"